Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Feb;20(2):150-153.
doi: 10.1016/j.jtho.2024.10.014.

Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLC

Vincent K Lam  1 , Shirish M Gadgeel  2
Affiliations
Free article
Editorial

Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLC

Vincent K Lam et al. J Thorac Oncol. 2025 Feb.
Free article

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure Dr. Lam has served in a consultant/advisory role for Pfizer, Genentech/Roche, Iovance Biotherapeutics, Anheart Therapeutics, Takeda, Seattle Genetics, Bristol Myers Squibb, AstraZeneca, Guardant Health, and has received research funding from GlaxoSmithKline, Bristol Myers Squibb, AstraZeneca, Merck, and Seattle Genetics. Dr. Gadgeel has served in a consulting/advisory role with Genentech/Roche, Boehringer Ingelheim, AstraZeneca, AbbVie, Astellas, Pfizer, Merck, Eisai, Takeda, Eli Lilly, Bristol Myers Squibb, Daiichi Sankyo, Gilead, Nuvation, Amgen, and has received travel support from Mirati and Merck.

Publication types

LinkOut - more resources